MarginsXMarginsX
Home › Data Desk › Fairmount Funds Management LLC reports owning 20.0% of Mentari Therapeutics Inc.

MarginsX Data Desk · 13D stakes · Name or ticker change · Mergers and acquisitions · Reverse split

Fairmount Funds Management LLC reports owning 20.0% of Mentari Therapeutics Inc.

In a Schedule 13D filed Nov 12, 2026, Fairmount Funds Management LLC reported holding 10.6 million shares of Mentari Therapeutics Inc. (MTRI) as of Nov 6, 2026, 20.0% of the class. (SEC EDGAR, SCHEDULE 13D, Nov 12, 2026)

By the MarginsX Data Desk, automated. Published November 14, 2026. Data as of November 12, 2026.

Line chart of Mentari Therapeutics Inc. (MTRI) daily closes from Jul 6, 2026 to Nov 12, 2026, with the 13D filing on Nov 12, 2026 marked.

What the filer says it intends

On the purpose of the transaction, the filing says: “99% of the Company in the aggregate, based upon the Company's aggregate outstanding shares as of November 6, 2026. The Reporting Persons' securities include 10,555,507 shares of Common Stock directly held by Fund II, and exclude (i) 4,013,000 shares of Common Stock issuable upon conversion of 4,013 shares of Series …” (SEC EDGAR, SCHEDULE 13D, Nov 12, 2026)

The stock

The Nasdaq screener puts its market value at $986.0M. (Nasdaq stock screener, Nov 13, 2026)

Follow it up

The company's page on MarginsX, with its filings, health check and ownership. (capital.sophiaxt.com/stocks/MTRI)

The filing on SEC EDGAR. (sec.gov)

The filing in the MarginsX reader. (MarginsX reader)

Automated from SEC filings and market data by the MarginsX Data Desk, written by template with no AI. For information only. Not investment advice.

Facts behind this article

FactValueSourceAs of
FilerFairmount Funds Management LLCSource2026-11-12
Pct19.99 %Source2026-11-12
NameMentari Therapeutics Inc.Source2026-11-13
FormSchedule 13DSource2026-11-12
FiledNov 12, 2026Source2026-11-12
Shares10,555,507 sharesSource2026-11-12
WhoMentari Therapeutics Inc. (MTRI)Source2026-11-13
SymbolMTRISource2026-11-13
Event dateNov 6, 2026Source2026-11-12
Purpose99% of the Company in the aggregate, based upon the Company'Source2026-11-12
Cap986,035,774 USDSource2026-11-13

Sources

Automated from SEC filings and market data. No AI. For information only. Not investment advice.

Discuss in MarginsX More from the Data Desk

More on MarginsX

Companies in this article

Topics

Related Data Desk stories

Every Data Desk article: /desk · RSS